| Amity Blythe Sparks, RN, BSN | |
|
859 E Melton Dr, Jay, OK 74346-2704 | |
| (918) 253-1761 | |
| Not Available |
| Full Name | Amity Blythe Sparks |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 859 E Melton Dr, Jay, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558946277 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | R0094749 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Amity Blythe Sparks, RN, BSN Po Box 350, Jay, OK 74346-0350 Ph: (918) 253-1761 | Amity Blythe Sparks, RN, BSN 859 E Melton Dr, Jay, OK 74346-2704 Ph: (918) 253-1761 |
News Archive
Gender and a family history of alcoholism (FH) are two genetically determined factors known to affect someone's risk for developing alcohol-use disorders (AUDs). Adolescence is also a critical period for the development of AUDs; drinking habits can be unstable and environmental factors such as peer pressure may be substantial.
Even "minimally buzzed" drivers are more often to blame for fatal car crashes than the sober drivers they collide with, reports a University of California, San Diego study of accidents in the United States.
Today, the Lupus Research Institute (LRI) released results from the organization's first scientific research impact report entitled, A Decade of Impact in Lupus Research Driving Discovery through Innovation. The results from the report demonstrate a significant impact in lupus research, which has seen no new treatment options approved in 50 years.
Eli Lilly and Company (NYSE: LLY), Kowa Company, Limited, and Kowa's U.S. subsidiary, Kowa Pharmaceuticals America, Inc., today announced that Lilly and Kowa Pharmaceuticals America have entered into a co-promotion agreement in the United States to commercialize LIVALO® (pitavastatin). Lilly and Kowa have also entered into a licensing agreement in Latin America. LIVALO is a statin approved by the U.S. Food and Drug Administration (FDA) in August 2009 for the treatment of primary hyperlipidemia and mixed dyslipidemia.
Computer-based standing orders are more effective than computerized reminders to physicians in increasing influenza and pneumococcal vaccine administration for hospitalized patients, according to an article in the November 17 issue of JAMA.
› Verified 2 days ago
Katherine Anne Hollenbeck, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 859 E Melton Dr, Jay, OK 74346 Phone: 918-253-1738 | |
Holly Anne Marsh, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1015 W Washbourne St, Jay, OK 74346 Phone: 918-308-5513 Fax: 918-253-6645 | |
Kellsey Miner, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1015 W Washbourne St, Jay, OK 74346 Phone: 918-308-5513 | |
Emily Graham, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1015 W Washbourne St, Jay, OK 74346 Phone: 918-308-5513 | |
Haley Armbrister, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 859 E Melton Dr, Jay, OK 74346 Phone: 877-293-4271 | |
Kimberly Angel Blanton, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1015 W Washbourne St, Jay, OK 74346 Phone: 918-308-5513 Fax: 918-786-4435 |